Latest article
Fierce Pharma Asia—AstraZeneca-Junshi PD-1 deal; Takeda’s $1.2B diabetes selloff, Ovid epilepsy collab pullout
In a strangely structured deal, AstraZeneca has nationwide licensed Junshi Biosciences' PD-1 inhibitor for only one indication in China. Takeda continued to sell...
Certain Indicators You Could Be Getting Diabetes, Says CDC
There are three main types of diabetes:Type 1, Type 2, and Gestational diabetes (Diabetes During Pregnancy) - And Knowing What Its...